https://www.live-feeds.com/feed/eli-lilly-ceo-says-700-000-new-seniors-have-started-glp-1s-after-medicare-coverage-and-70-are-on-lilly-drugsContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/eli-lilly-ceo-says-700-000-new-seniors-have-started-glp-1s-after-medicare-coverage-and-70-are-on-lilly-drugshttps://www.live-feeds.com/feed/eli-lilly-ceo-says-700-000-new-seniors-have-started-glp-1s-after-medicare-coverage-and-70-are-on-lilly-drugs#u83037Thu, 24 Sep 2026 22:50:39 +0000Eli Lilly CEO reports that 700,000 seniors began using GLP-1 obesity treatments after gaining Medicare coverage, with 70% of those patients choosing Lilly drugs. To support growth, the company has broken ground on a $6.5 billion manufacturing facility in Houston's Generation Park, planned for 2030. This site is one of ten U.S. manufacturing locations announced since 2020. Additionally, some state Medicaid programs are expanding to cover GLP-1 weight loss medications, while the Medicare GLP-1 Bridge program is viewed as a potential financial headwind for insurers.Why it mattersGLP-1 medica